422 related articles for article (PubMed ID: 21425881)
1. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
Logrip ML; Koob GF; Zorrilla EP
CNS Drugs; 2011 Apr; 25(4):271-87. PubMed ID: 21425881
[TBL] [Abstract][Full Text] [Related]
2. Stress, corticotropin-releasing factor, and drug addiction.
Koob GF
Ann N Y Acad Sci; 1999; 897():27-45. PubMed ID: 10676433
[TBL] [Abstract][Full Text] [Related]
3. Role of withdrawal in reinstatement of morphine-conditioned place preference.
Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
[TBL] [Abstract][Full Text] [Related]
4. Review. Neurobiological mechanisms for opponent motivational processes in addiction.
Koob GF; Le Moal M
Philos Trans R Soc Lond B Biol Sci; 2008 Oct; 363(1507):3113-23. PubMed ID: 18653439
[TBL] [Abstract][Full Text] [Related]
5. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
Lowery EG; Thiele TE
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
[TBL] [Abstract][Full Text] [Related]
7. The corticotropin-releasing factor receptor-2 mediates the motivational effect of opiate withdrawal.
Rouibi K; Contarino A
Neuropharmacology; 2013 Oct; 73():41-7. PubMed ID: 23707482
[TBL] [Abstract][Full Text] [Related]
8. The role of CRF and CRF-related peptides in the dark side of addiction.
Koob GF
Brain Res; 2010 Feb; 1314():3-14. PubMed ID: 19912996
[TBL] [Abstract][Full Text] [Related]
9. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence.
Bruijnzeel AW; Gold MS
Brain Res Brain Res Rev; 2005 Nov; 49(3):505-28. PubMed ID: 16269317
[TBL] [Abstract][Full Text] [Related]
10. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
Koob GF; Zorrilla EP
Curr Opin Investig Drugs; 2010 Jan; 11(1):63-71. PubMed ID: 20047160
[TBL] [Abstract][Full Text] [Related]
11. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.
Koob GF; Heinrichs SC
Brain Res; 1999 Nov; 848(1-2):141-52. PubMed ID: 10612706
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
[TBL] [Abstract][Full Text] [Related]
13. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
15. Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems.
George O; Le Moal M; Koob GF
Physiol Behav; 2012 Apr; 106(1):58-64. PubMed ID: 22108506
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
Lu L; Liu D; Ceng X
Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
[TBL] [Abstract][Full Text] [Related]
17. Neurocircuitry of alcohol addiction: synthesis from animal models.
Koob GF
Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
[TBL] [Abstract][Full Text] [Related]
18. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
Martin-Fardon R; Zorrilla EP; Ciccocioppo R; Weiss F
Brain Res; 2010 Feb; 1314():145-61. PubMed ID: 20026088
[TBL] [Abstract][Full Text] [Related]
19. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans.
Sarnyai Z
Ann N Y Acad Sci; 1998 Jun; 851():371-87. PubMed ID: 9668628
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
Bruijnzeel AW; Zislis G; Wilson C; Gold MS
Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
